Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
TYRATyra Biosciences, Inc.
| Figure | TYRATyra Biosciences, Inc.FY2025 · Dec |
|---|---|
| Revenue | — |
| Revenue, yoy | — |
| Net income | $119.95M |
| Net income, yoy | −38.7% |
| Net margin | — |
| Free cash flow | $95.28M |
| FCF margin | — |
| EPS, diluted | $2.01 |
Add another company.
Annual · USD
No annual figures on file for this.
From SEC EDGARSame fiscal periods, as filed